Bulk drugs maker to pop out ‘benchmark returns’ pill for Morgan Stanley

By Ankit Agarwal

  • 10 Feb 2021
Premium
Credit: Thinkstock

ZCL Chemicals Ltd is all set to serve up benchmark returns for Morgan Stanley PE Asia as the investor gets ready to exit the active pharmaceutical ingredient maker after over four years. Morgan Stanley will be exiting under a deal announced on Monday as part of which private equity firm Advent ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.